Arintra, the leading GenAI-native autonomous medical coding platform for healthcare organizations, announced it achieved eight times year-over-year revenue growth in 2025, driven by rapid adoption across health systems and physician groups. The company reported a more than fivefold increase in monthly coding volume and now autonomously codes claims across a majority of ambulatory care specialties, including primary care, cardiology, pediatrics, urgent care, emergency departments, inpatient rounding, and diagnostic fields such as radiology and pathology. As healthcare organizations face tightening margins and evolving reimbursement models, Arintra’s success underscores the growing demand for transparent, audit-ready coding solutions that integrate seamlessly into existing workflows. The company closed 13 enterprise deals in just 100 days, reflecting strong market confidence in AI-driven tools that deliver measurable financial impact quickly. Arintra’s platform integrates directly with major EHR systems like Epic and athenahealth, enabling customers to go live and begin realizing results within four to six weeks. Every partnership begins with a proof-of-value phase, allowing organizations to validate performance before scaling across multiple specialties. This approach has proven highly effective, with 100% of customers transitioning from proof-of-value to full enterprise deployment. Customers are achieving significant outcomes: an average revenue uplift of 5% to 8%, at least a 32% reduction in coding costs, and a 64% decrease in pre-account receivable days. These improvements translate to a typical return on investment exceeding 10 times the initial spend. “We consistently hear from health systems and provider groups that they’re expanding services, but financial pressures and administrative workloads are overwhelming their teams,” said Nitesh Shroff, Chief Executive Officer and Co-Founder of Arintra. “This is intensifying the need for AI solutions that deliver real, immediate improvements in efficiency and financial performance.” Preeti Bhargava, Chief Technology Officer and Co-Founder, emphasized the company’s commitment to results: “Our growth is rooted in a simple principle—prove value first, then scale. That’s the foundation of everything we do, and it’s what we’ll continue to prioritize as we expand into new areas of the revenue cycle.” In 2026, Arintra plans to extend its product roadmap to address additional revenue-cycle challenges, including prior authorizations and denial management. This expansion aims to help providers close financial gaps earlier and more effectively. The announcement follows Arintra’s $21 million Series A funding round in August 2025, with plans to raise additional capital later this year. The company’s outcomes-first strategy continues to differentiate it in a competitive AI healthcare landscape. Arintra’s platform leverages advanced generative AI combined with deep clinical expertise to autonomously code medical charts with high accuracy—without requiring human intervention. Unlike add-on tools, Arintra operates directly within the EHR, ensuring seamless adoption, zero workflow disruption, and no compromise on data integrity. By addressing coding gaps, documentation issues, and unchallenged denials, Arintra helps health systems recover missed revenue, achieve 5%+ revenue growth, reduce pre-A/R days by over 64%, and cut denials by more than 43%. For more information about Arintra or its autonomous coding platform, visit arintra.com.